art

Artmarket.com: Double-digit growth in Q2 2025, Revolutionary Artprice-Perplexity AI rapprochement: The Mixed Subscription for the Second Half of 2025/2026 Will Redefine the Intelligence of the Art Market

PARIS, Aug. 7, 2025 /PRNewswire/ -- The Board of Directors, its founding President, and the employees of Artprice are mobilizing…

6 months ago

Art of Time: A Decade of Horological Excellence

Art of Time celebrates a decade of shaping India's luxury watch landscape with a special collaboration with Roger Dubuis that bridges…

6 months ago

Automobili Lamborghini captivates Sylt: performance meets art

An exclusive showcase of Italian super sports cars, design and lifestyle at the Werkhallen Gallerie Kampen on the famous German…

6 months ago

ART COMES TO LIFE AT RUNWAL RAAYA IN WORLI WITH TAO ART GALLERY COLLAB

MUMBAI, India, July 16, 2025 /PRNewswire/ --  Runwal Realty, one of India's most trusted luxury developers, is proud to announce a…

6 months ago

Art Never Melts: Huion’s Prime Day 2025 Cool Creative Deals

LOS ANGELES, July 8, 2025 /PRNewswire/ -- When the cruel summer heat meets Prime Day, why not stay cool indoors and…

7 months ago

Runwal Raaya Hosts an Immersive Evening with Tao Art Gallery

Runwal Raaya transforms into a canvas for contemporary Indian artBollywood's Neha Dhupia & Angad Bedi grace the immersive showcaseAn evening…

7 months ago

“The Most Important Thing About Art is Freedom,” says AR Rahman at IGF London 2025

Oscar-winning composer on scent cinema, AI, and the reinvention of Indian music culture LONDON, June 22, 2025 /PRNewswire/ --  In…

7 months ago

“AI and the Art Market” by Arte, with Artprice by Artmarket and analysis by Perplexity.AI Labs

PARIS, June 16, 2025 /PRNewswire/ -- This Sunday, June 15th, 2025, the Franco-German TV channel Arte broadcast the documentary "AI…

7 months ago

[Ad hoc announcement pursuant to Art. 53 LR] Roche provides safety update on Elevidys gene therapy for Duchenne muscular dystrophy in non-ambulatory patients

After a thorough clinical review, the benefit-risk for the use of Elevidys in non-ambulatory patients with Duchenne has been re-assessed,…

7 months ago

IPSEN – Buy-back programme – Art 5 of MAR – Week 23 – 2025

Aggregated presentation by day and by market Statement of transactions in own shares from June 2nd to June 6th 2025       Name…

7 months ago